J
Joseph R. Dalovisio
Researcher at Ochsner Health System
Publications - 34
Citations - 4258
Joseph R. Dalovisio is an academic researcher from Ochsner Health System. The author has contributed to research in topics: Mycobacterium fortuitum & Health care. The author has an hindex of 19, co-authored 34 publications receiving 3965 citations. Previous affiliations of Joseph R. Dalovisio include Baylor College of Medicine & Ochsner Medical Center.
Papers
More filters
Journal ArticleDOI
Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.
TL;DR: Vancomycin is a glycopeptide antibiotic that is one of the most widely used antibiotics in the United States for the treatment of serious gram-positive streptococcus aureus infections.
Journal ArticleDOI
Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists
Michael J. Rybak,Ben M. Lomaestro,John C. Rotschafer,Robert C. Moellering,Willam A. Craig,Marianne Billeter,Joseph R. Dalovisio,Donald P. Levine +7 more
TL;DR: A literature review of existing evidence regarding vancomycin dosing and monitoring of serum concentrations, in addition to patient outcomes combined with expert opinion regarding the drug's pharmacokinetic, pharmacodynamic, and safety record, resulted in new recommendations for targeting and adjustment of vancomYcin therapy.
Journal ArticleDOI
Practice Guidelines for Outpatient Parenteral Antimicrobial Therapy
Alan D. Tice,Susan J. Rehm,Joseph R. Dalovisio,John S. Bradley,Lawrence P. Martinelli,Donald R. Graham,R. Brooks Gainer,Mark J. Kunkel,Robert W. Yancey,David N. Williams +9 more
TL;DR: These guidelines were formulated to assist physicians and other health care professionals with various aspects of the administration of outpatient parenteral antimicrobial therapy (OPAT).
Journal ArticleDOI
Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.
Michael J. Rybak,Michael J. Rybak,Ben M. Lomaestro,John C. Rotschafer,Robert C. Moellering,William A. Craig,Marianne Billeter,Joseph R. Dalovisio,Donald P. Levine +8 more
TL;DR: The area under the concentration‐time curve (AUC):minimum inhibitory concentration (MIC) ratio is the most useful pharmacodynamic parameter to predict vancomycin effectiveness and a target ratio of 400 or greater to eradicate S. aureus infections is suggested.
Journal ArticleDOI
Practice Guidelines for Outpatient Parenteral Antimicrobial Therapy
Alan D. Tice,Susan J. Rehm,Joseph R. Dalovisio,John S. Bradley,Lawrence P. Martinelli,Donald R. Graham,R. Brooks Gainer,Mark J. Kunkel,Robert W. Yancey,David N. Williams +9 more
TL;DR: This work presents a meta-analysis of 125 cases of Clostridium difficile infection in mice over a 12-month period and shows clear patterns of disease progression that can be diagnosed using a simple, straightforward, and efficient two-step procedure.